Expression of Foxp3, CD25 and IL-2 in the B16F10 cancer cell line and melanoma is correlated with tumor growth in mice

Roncador, 2005, Foxp3, a selective marker for a subset of adult T-cell leukemia/lymphoma, Leukemia, 19, 2247, 10.1038/sj.leu.2403965

Lu, 2009, FOXP3 expression and prognosis: role of both the tumor and T cells, J Clin Oncol, 27, 1735, 10.1200/JCO.2008.20.0675

von Boehmer, 2005, Mechanisms of suppression by suppressor T cells, Nat Immunol, 6, 338, 10.1038/ni1180

Niu, 2011, Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction, Cancer Immunol Immunother, 60, 1109, 10.1007/s00262-011-1025-3

Karanikas, 2008, Foxp3 expression in human cancer cells, J Transl Med, 6, 19, 10.1186/1479-5876-6-19

Merlo, 2009, FOXP3 expression and overall survival in breast cancer, J Clin Oncol, 27, 1746, 10.1200/JCO.2008.17.9036

Chin, 2006, Malignant melanoma: genetics and therapeutics in the genomic era, Genes Dev, 20, 2149, 10.1101/gad.1437206

Hinz, 2007, Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer, Cancer Res, 67, 8344, 10.1158/0008-5472.CAN-06-3304

Ebert, 2008, The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells, Cancer Res, 68, 3001, 10.1158/0008-5472.CAN-07-5664

Monti, 2004, A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile, Virchows Arch, 445, 236, 10.1007/s00428-004-1053-x